McKesson Corporation
Recent
price
P/E
ratio
div
yld
0.35%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- McKesson Corporation (NYSE: MCK) operates as a diversified healthcare services company, primarily engaged in pharmaceutical distribution, medical-surgical supply distribution, oncology and multispecialty solutions, and prescription technology services. The company distributes pharmaceuticals and medical supplies through its North American Pharmaceutical segment, which serves retail and community pharmacies, specialty care settings, and health systems across the United States and Canada via a network of distribution centers; its Oncology and Multispecialty segment provides practice management, technology solutions, specialty drug distribution, clinical trial services, group purchasing, and pharmacy solutions for community-based oncology practices and providers in retina and ophthalmology; its Medical-Surgical Solutions segment merchandises and distributes more than 285,000 national brand products alongside McKesson's own brands of medical-surgical supplies, pharmaceuticals, laboratory equipment, and supplies to physician offices, surgery centers, long-term care providers, home health agencies, health systems, government facilities, and online retailers in the United States; and its Prescription Technology Solutions segment offers medication access, affordability, and adherence programs, including prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support connecting patients, pharmacies, providers, payers, and biopharma companies. [fetch:https://www.mckesson.com/about-us/business-segments/] Founded in 1833 and headquartered in Irving, Texas, McKesson serves healthcare providers, pharmacies, biopharma manufacturers, governments, and consumers primarily in North America, with additional distribution and retail operations in Norway, which it agreed to sell in August 2025. [fetch:https://www.mckesson.com/about-us/history/] In recent strategic developments, McKesson acquired a controlling interest in Community Oncology Revitalization Enterprise Ventures (Core Ventures), associated with Florida Cancer Specialists & Research Institute, for $2.49 billion in August 2024 to bolster oncology care; welcomed Florida Cancer Specialists as a member of The US Oncology Network; acquired a controlling interest in PRISM Vision Group to expand into ophthalmology and retina care; formed a joint venture between US Oncology Research and HCA Healthcare's Sarah Cannon Research Institute to advance oncology research and clinical trials; and announced in September 2025 a corporate restructuring into four segments—North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions—effective fiscal 2026, alongside plans to separate the Medical-Surgical Solutions segment and updated long-term growth targets including 13% to 16% adjusted earnings per share growth. [fetch:https://www.mckesson.com/about-us/history/]
Company News
McKesson: AI And FDA Overhaul Likely To Overtake Regulatory Drag In 2027
McKesson Corporation $MCK Shares Acquired by Carnegie Investment Counsel
McKesson (MCK) Stock Dips While Market Gains: Key Facts
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
McKesson Corporation Declares Quarterly Dividend
McKesson (MCK) Outperforms Broader Market: What You Need to Know
McKesson Corporation $MCK Shares Purchased by IFP Advisors Inc
Counterpoint Mutual Funds LLC Buys 1,788 Shares of McKesson Corporation $MCK
McKesson Corporation $MCK Stock: Aspiriant LLC Grows Holdings
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
691 Shares in McKesson Corporation $MCK Bought by Sax Wealth Advisors LLC
McKesson Corporation $MCK Stock: First Citizens Bank & Trust Co. Increases Stake
McKesson (MCK) Ascends While Market Falls: Some Facts to Note
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
McKesson Corporation $MCK Stock Acquired by Terra Nova Asset Management LLC
Vertrix Wealth Management LLC Sells 593 Shares of McKesson Corporation $MCK
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Sapient Capital LLC Acquires New Shares in McKesson Corporation $MCK
Here's Why McKesson (MCK) is a Strong Growth Stock
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?